311 related articles for article (PubMed ID: 8665881)
1. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
[TBL] [Abstract][Full Text] [Related]
2. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of atracurium-induced block in obese patients.
Kirkegaard-Nielsen H; Lindholm P; Petersen HS; Severinsen IK
Can J Anaesth; 1998 Jan; 45(1):39-41. PubMed ID: 9466025
[TBL] [Abstract][Full Text] [Related]
4. Effect of neostigmine at different levels of mivacurium-induced neuromuscular blockade.
Trévien V; Lienhart A; Just B; Chandon M; Baras E; Camatte S
Acta Anaesthesiol Scand Suppl; 1995; 106():66-9. PubMed ID: 8533550
[TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
[TBL] [Abstract][Full Text] [Related]
6. Conditions to optimise the reversal action of neostigmine upon a vecuronium-induced neuromuscular block.
Baurain MJ; Dernovoi BS; D'Hollander AA; Hennart DA; Cantraine FR
Acta Anaesthesiol Scand; 1996 May; 40(5):574-8. PubMed ID: 8792887
[TBL] [Abstract][Full Text] [Related]
7. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Bülow K
J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
[TBL] [Abstract][Full Text] [Related]
8. Neuromuscular and cardiovascular effects of neostigmine and methyl-atropine administered at different degrees of rocuronium-induced neuromuscular block.
Van den Broek L; Proost JH; Wierda JM; Njoo MD; Hennis PJ
Eur J Anaesthesiol; 1994 Nov; 11(6):481-7. PubMed ID: 7851356
[TBL] [Abstract][Full Text] [Related]
9. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
Stevens JB; Walker SC; Fontenot JP
Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
[TBL] [Abstract][Full Text] [Related]
10. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children.
Bevan JC; Collins L; Fowler C; Kahwaji R; Rosen HD; Smith MF; de Scheepers LD; Stephenson CA; Bevan DR
Anesth Analg; 1999 Aug; 89(2):333-9. PubMed ID: 10439743
[TBL] [Abstract][Full Text] [Related]
11. Neuromuscular effects of vecuronium and neostigmine in Montreal and Paris.
Salib Y; Frossard J; Plaud B; Debaene B; Meistelman C; Donati F
Can J Anaesth; 1994 Oct; 41(10):908-12. PubMed ID: 8001209
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine.
Fuchs-Buder T; Meistelman C; Alla F; Grandjean A; Wuthrich Y; Donati F
Anesthesiology; 2010 Jan; 112(1):34-40. PubMed ID: 19952724
[TBL] [Abstract][Full Text] [Related]
13. Relative contribution of pre- and post-synaptic effects to the neostigmine-induced recovery of neuromuscular transmission blocked by vecuronium.
Baso AC; Serra CS; Oliveira AC
Fundam Clin Pharmacol; 2011 Feb; 25(1):123-30. PubMed ID: 20408882
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting atracurium reversal time.
Kirkegaard-Nielsen H; Severinsen IK; Pedersen HS; Lindholm P
Acta Anaesthesiol Scand; 1999 Sep; 43(8):834-41. PubMed ID: 10492412
[TBL] [Abstract][Full Text] [Related]
15. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade.
Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Pedersen HS; Jensen EW
Can J Anaesth; 1996 Sep; 43(9):932-8. PubMed ID: 8874911
[TBL] [Abstract][Full Text] [Related]
16. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
Smith CE; Donati F; Bevan DR
Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
[TBL] [Abstract][Full Text] [Related]
17. Comparison of recovery following rapacuronium, with and without neostigmine, and succinylcholine.
Hayes A; Breslin D; Reid J; Mirakhur RK
Anaesthesia; 2000 Sep; 55(9):859-63. PubMed ID: 10947748
[TBL] [Abstract][Full Text] [Related]
18. Method of intraoperative monitoring of neuromuscular function and residual blockade in the recovery room.
Jones KA; Lennon RL; Hosking MP
Minn Med; 1992 Jul; 75(7):23-6. PubMed ID: 1357537
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of vecuronium-induced neuromuscular block in patients pretreated with magnesium sulphate: dose-effect relationship of neostigmine.
Fuchs-Buder T; Ziegenfuss T; Lysakowski K; Tassonyi E
Br J Anaesth; 1999 Jan; 82(1):61-5. PubMed ID: 10325838
[TBL] [Abstract][Full Text] [Related]
20. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
